

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neutrophil activation involved in immune response (GO:0002283) | 5.81937385 |
| 2 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.87669761 |
| 3 | neutrophil activation (GO:0042119) | 4.30369969 |
| 4 | positive regulation of interferon-alpha production (GO:0032727) | 4.28602140 |
| 5 | respiratory burst (GO:0045730) | 4.23240133 |
| 6 | granulocyte activation (GO:0036230) | 4.13286126 |
| 7 | response to peptidoglycan (GO:0032494) | 4.13032246 |
| 8 | regulation of interferon-alpha production (GO:0032647) | 4.07499677 |
| 9 | immunoglobulin mediated immune response (GO:0016064) | 3.97595065 |
| 10 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.85840527 |
| 11 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.80102319 |
| 12 | superoxide anion generation (GO:0042554) | 3.78261410 |
| 13 | reactive oxygen species biosynthetic process (GO:1903409) | 3.77660877 |
| 14 | detection of molecule of bacterial origin (GO:0032490) | 3.75258142 |
| 15 | cellular extravasation (GO:0045123) | 3.74752335 |
| 16 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.73000578 |
| 17 | detection of other organism (GO:0098543) | 3.66046989 |
| 18 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.61379255 |
| 19 | protein localization to endosome (GO:0036010) | 3.61359155 |
| 20 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.59032536 |
| 21 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.57953108 |
| 22 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.57953108 |
| 23 | modulation by symbiont of host immune response (GO:0052553) | 3.57953108 |
| 24 | positive regulation by symbiont of host defense response (GO:0052509) | 3.57953108 |
| 25 | modulation by symbiont of host defense response (GO:0052031) | 3.57953108 |
| 26 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.57953108 |
| 27 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.56774130 |
| 28 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.53272769 |
| 29 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.47373771 |
| 30 | myeloid dendritic cell activation (GO:0001773) | 3.47266346 |
| 31 | positive regulation of antigen processing and presentation (GO:0002579) | 3.47003606 |
| 32 | cellular response to type I interferon (GO:0071357) | 3.45727892 |
| 33 | type I interferon signaling pathway (GO:0060337) | 3.45727892 |
| 34 | regulation of gamma-delta T cell activation (GO:0046643) | 3.42428677 |
| 35 | response to type I interferon (GO:0034340) | 3.40525140 |
| 36 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.39771337 |
| 37 | B cell receptor signaling pathway (GO:0050853) | 3.37593164 |
| 38 | detection of external biotic stimulus (GO:0098581) | 3.35816493 |
| 39 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.35545831 |
| 40 | positive regulation of mast cell activation (GO:0033005) | 3.34240279 |
| 41 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.34212948 |
| 42 | natural killer cell mediated immunity (GO:0002228) | 3.34212948 |
| 43 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.34182733 |
| 44 | defense response to protozoan (GO:0042832) | 3.33496220 |
| 45 | myeloid cell activation involved in immune response (GO:0002275) | 3.32219953 |
| 46 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.29488813 |
| 47 | negative regulation of viral genome replication (GO:0045071) | 3.28762436 |
| 48 | leukocyte aggregation (GO:0070486) | 3.27276580 |
| 49 | detection of bacterium (GO:0016045) | 3.25836947 |
| 50 | cellular response to exogenous dsRNA (GO:0071360) | 3.25620363 |
| 51 | positive regulation of interleukin-12 production (GO:0032735) | 3.25451755 |
| 52 | mast cell activation (GO:0045576) | 3.25292025 |
| 53 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.25253490 |
| 54 | response to host (GO:0075136) | 3.25253490 |
| 55 | response to host defenses (GO:0052200) | 3.25253490 |
| 56 | regulation of RIG-I signaling pathway (GO:0039535) | 3.24840497 |
| 57 | B cell mediated immunity (GO:0019724) | 3.24448915 |
| 58 | sequestering of actin monomers (GO:0042989) | 3.24399117 |
| 59 | negative regulation of interleukin-12 production (GO:0032695) | 3.22984487 |
| 60 | cellular response to zinc ion (GO:0071294) | 3.22980396 |
| 61 | negative regulation of interleukin-17 production (GO:0032700) | 3.22865255 |
| 62 | positive regulation of B cell differentiation (GO:0045579) | 3.21261657 |
| 63 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.20245123 |
| 64 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.19936120 |
| 65 | dendritic cell chemotaxis (GO:0002407) | 3.19595742 |
| 66 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.19455579 |
| 67 | cellular response to interferon-beta (GO:0035458) | 3.15266873 |
| 68 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.15157738 |
| 69 | myeloid dendritic cell differentiation (GO:0043011) | 3.13949242 |
| 70 | regulation of activation of Janus kinase activity (GO:0010533) | 3.13591673 |
| 71 | leukocyte mediated cytotoxicity (GO:0001909) | 3.13369317 |
| 72 | hypotonic response (GO:0006971) | 3.13002724 |
| 73 | regulation of mast cell activation (GO:0033003) | 3.11608439 |
| 74 | positive regulation of T cell chemotaxis (GO:0010820) | 3.10580669 |
| 75 | regulation of T cell chemotaxis (GO:0010819) | 3.10580669 |
| 76 | T cell migration (GO:0072678) | 3.10366552 |
| 77 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.10022327 |
| 78 | positive regulation of lymphocyte migration (GO:2000403) | 3.08735380 |
| 79 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.08157084 |
| 80 | negative regulation of cell killing (GO:0031342) | 3.08157084 |
| 81 | positive regulation of interferon-beta production (GO:0032728) | 3.07747951 |
| 82 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.07468411 |
| 83 | positive regulation of mast cell degranulation (GO:0043306) | 3.07468411 |
| 84 | positive regulation of T cell migration (GO:2000406) | 3.06446569 |
| 85 | regulation of antigen processing and presentation (GO:0002577) | 3.04446925 |
| 86 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.03927473 |
| 87 | pinocytosis (GO:0006907) | 3.02997497 |
| 88 | macrophage activation involved in immune response (GO:0002281) | 3.02885153 |
| 89 | negative regulation of mast cell activation (GO:0033004) | 3.01891172 |
| 90 | myeloid leukocyte activation (GO:0002274) | 3.01056024 |
| 91 | dendritic cell migration (GO:0036336) | 2.99960903 |
| 92 | eosinophil chemotaxis (GO:0048245) | 2.99475369 |
| 93 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.98806246 |
| 94 | T-helper 1 type immune response (GO:0042088) | 2.98499836 |
| 95 | response to protozoan (GO:0001562) | 2.97518036 |
| 96 | detection of biotic stimulus (GO:0009595) | 2.97420863 |
| 97 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.95254164 |
| 98 | regulation of leukocyte degranulation (GO:0043300) | 2.93150176 |
| 99 | monocyte chemotaxis (GO:0002548) | 2.92854734 |
| 100 | negative thymic T cell selection (GO:0045060) | 2.92391652 |
| 101 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.91905937 |
| 102 | positive regulation of type 2 immune response (GO:0002830) | 2.90300353 |
| 103 | regulation of mast cell degranulation (GO:0043304) | 2.90090944 |
| 104 | leukocyte degranulation (GO:0043299) | 2.89737412 |
| 105 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.89534700 |
| 106 | interferon-gamma production (GO:0032609) | 2.87163251 |
| 107 | lymphocyte chemotaxis (GO:0048247) | 2.86518357 |
| 108 | response to muramyl dipeptide (GO:0032495) | 2.84917606 |
| 109 | cellular response to interferon-gamma (GO:0071346) | 2.84537506 |
| 110 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.84278431 |
| 111 | regulation of lymphocyte chemotaxis (GO:1901623) | 2.84094039 |
| 112 | response to host immune response (GO:0052572) | 2.83885147 |
| 113 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.83885147 |
| 114 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.83688619 |
| 115 | germinal center formation (GO:0002467) | 2.83533034 |
| 116 | positive regulation of macrophage differentiation (GO:0045651) | 2.82972042 |
| 117 | phagosome maturation (GO:0090382) | 2.82745680 |
| 118 | regulation of B cell differentiation (GO:0045577) | 2.82223245 |
| 119 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.80819999 |
| 120 | histamine secretion (GO:0001821) | 2.80407399 |
| 121 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.80325884 |
| 122 | regulation of monocyte chemotaxis (GO:0090025) | 2.80280005 |
| 123 | regulation of hypersensitivity (GO:0002883) | 2.79252402 |
| 124 | positive thymic T cell selection (GO:0045059) | 2.77425477 |
| 125 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.77097475 |
| 126 | negative T cell selection (GO:0043383) | 2.76626354 |
| 127 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.76611878 |
| 128 | regulation of macrophage cytokine production (GO:0010935) | 2.74953105 |
| 129 | negative regulation of T cell mediated immunity (GO:0002710) | 2.73398947 |
| 130 | response to interleukin-15 (GO:0070672) | 2.72868998 |
| 131 | response to laminar fluid shear stress (GO:0034616) | 2.72602616 |
| 132 | embryonic process involved in female pregnancy (GO:0060136) | 2.69475029 |
| 133 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.68668538 |
| 134 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.67521042 |
| 135 | membrane raft organization (GO:0031579) | 2.66174740 |
| 136 | macrophage activation (GO:0042116) | 2.65557665 |
| 137 | microglial cell activation (GO:0001774) | 2.65066676 |
| 138 | stress fiber assembly (GO:0043149) | 2.62677560 |
| 139 | hepatocyte apoptotic process (GO:0097284) | 2.61222682 |
| 140 | cortical actin cytoskeleton organization (GO:0030866) | 2.60419621 |
| 141 | positive regulation of leukocyte degranulation (GO:0043302) | 2.59923248 |
| 142 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.58093444 |
| 143 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.57104358 |
| 144 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.56111236 |
| 145 | COPI coating of Golgi vesicle (GO:0048205) | 2.52792003 |
| 146 | Golgi transport vesicle coating (GO:0048200) | 2.52792003 |
| 147 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.51830083 |
| 148 | T cell selection (GO:0045058) | 2.50054178 |
| 149 | nuclear pore complex assembly (GO:0051292) | 2.46753616 |
| 150 | regulation of tolerance induction (GO:0002643) | 2.45669289 |
| 151 | megakaryocyte development (GO:0035855) | 2.42094502 |
| 152 | regulation of regulated secretory pathway (GO:1903305) | 2.41256837 |
| 153 | regulation of defense response to virus by virus (GO:0050690) | 2.40606480 |
| 154 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.40495612 |
| 155 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.40119080 |
| 156 | positive regulation of macrophage cytokine production (GO:0060907) | 2.39565526 |
| 157 | thymic T cell selection (GO:0045061) | 2.39262231 |
| 158 | regulation of T cell tolerance induction (GO:0002664) | 2.38019800 |
| 159 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.37129389 |
| 160 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.37104429 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 7.05984800 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.81330049 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.31757316 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.15215950 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.84543483 |
| 6 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.39625749 |
| 7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.05375025 |
| 8 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.96114637 |
| 9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.78832493 |
| 10 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.59792201 |
| 11 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.38397231 |
| 12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.22020094 |
| 13 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.14222691 |
| 14 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.12055769 |
| 15 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.00051963 |
| 16 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.96190083 |
| 17 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.92181073 |
| 18 | MYC_22102868_ChIP-Seq_BL_Human | 2.83458374 |
| 19 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.82731810 |
| 20 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.22804202 |
| 21 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.17944870 |
| 22 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.11384606 |
| 23 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.09397385 |
| 24 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.03554636 |
| 25 | MYB_26560356_Chip-Seq_TH2_Human | 2.00262061 |
| 26 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.96764478 |
| 27 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.95614116 |
| 28 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.95241944 |
| 29 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.90862061 |
| 30 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.87057892 |
| 31 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.79403890 |
| 32 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.72986000 |
| 33 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.72319956 |
| 34 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.62684312 |
| 35 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.62475485 |
| 36 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.62056823 |
| 37 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.61811395 |
| 38 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.57409303 |
| 39 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.56206328 |
| 40 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.51943947 |
| 41 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.51296993 |
| 42 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.49903663 |
| 43 | * MYB_26560356_Chip-Seq_TH1_Human | 1.49527349 |
| 44 | UTX_26944678_Chip-Seq_JUKART_Human | 1.48331035 |
| 45 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.46993066 |
| 46 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.46908334 |
| 47 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.46658055 |
| 48 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46097370 |
| 49 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.44883332 |
| 50 | GATA1_22025678_ChIP-Seq_K562_Human | 1.43166797 |
| 51 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.42485452 |
| 52 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.41226513 |
| 53 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.40867653 |
| 54 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.39328530 |
| 55 | GATA3_26560356_Chip-Seq_TH2_Human | 1.38803880 |
| 56 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.37354738 |
| 57 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.35626295 |
| 58 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.33143189 |
| 59 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.32669639 |
| 60 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.32203123 |
| 61 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.31499146 |
| 62 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.31032019 |
| 63 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.30499193 |
| 64 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.29007673 |
| 65 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26578311 |
| 66 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.24978373 |
| 67 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.24092180 |
| 68 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.20709523 |
| 69 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.20532873 |
| 70 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.19904721 |
| 71 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19233647 |
| 72 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.19147643 |
| 73 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.18334607 |
| 74 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.17860812 |
| 75 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.17380470 |
| 76 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.16341341 |
| 77 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.16228362 |
| 78 | MAF_26560356_Chip-Seq_TH1_Human | 1.15774064 |
| 79 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.13160459 |
| 80 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.11837104 |
| 81 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.11565977 |
| 82 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.10517761 |
| 83 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.10200467 |
| 84 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.08599130 |
| 85 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.08297421 |
| 86 | MAF_26560356_Chip-Seq_TH2_Human | 1.07635784 |
| 87 | GATA1_19941826_ChIP-Seq_K562_Human | 1.06093041 |
| 88 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.04509856 |
| 89 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.04375664 |
| 90 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.03731629 |
| 91 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.02974563 |
| 92 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.02402422 |
| 93 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.01302210 |
| 94 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.99075869 |
| 95 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.98771771 |
| 96 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98520303 |
| 97 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.98457691 |
| 98 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.98384204 |
| 99 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.98119927 |
| 100 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.97170518 |
| 101 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97109050 |
| 102 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.96824304 |
| 103 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.94981689 |
| 104 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.94546779 |
| 105 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.94458713 |
| 106 | GATA2_19941826_ChIP-Seq_K562_Human | 0.93786135 |
| 107 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.91270122 |
| 108 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.90931249 |
| 109 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.90369378 |
| 110 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.89398880 |
| 111 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.88633221 |
| 112 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.88335988 |
| 113 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.87323774 |
| 114 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.86183067 |
| 115 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.82568638 |
| 116 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.81901436 |
| 117 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.81630240 |
| 118 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.81630240 |
| 119 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.80928043 |
| 120 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.79198493 |
| 121 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.79158432 |
| 122 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.79158432 |
| 123 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.77441875 |
| 124 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.76013825 |
| 125 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.75622659 |
| 126 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.75144592 |
| 127 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.74208002 |
| 128 | * SMRT_27268052_Chip-Seq_Bcells_Human | 0.73454797 |
| 129 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.73214041 |
| 130 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.72696344 |
| 131 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.72211858 |
| 132 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.71604078 |
| 133 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.71286640 |
| 134 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.70129498 |
| 135 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.69968962 |
| 136 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.69889033 |
| 137 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.69470915 |
| 138 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.69097685 |
| 139 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.67041383 |
| 140 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.66862767 |
| 141 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.66677413 |
| 142 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.66249070 |
| 143 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.66097454 |
| 144 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.65225120 |
| 145 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.64484540 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 5.41329975 |
| 2 | MP0002148_abnormal_hypersensitivity_rea | 4.12964912 |
| 3 | MP0009785_altered_susceptibility_to | 3.98460619 |
| 4 | MP0005671_abnormal_response_to | 3.48556694 |
| 5 | MP0003436_decreased_susceptibility_to | 3.46127786 |
| 6 | MP0005000_abnormal_immune_tolerance | 3.25514908 |
| 7 | MP0003300_gastrointestinal_ulcer | 3.11401959 |
| 8 | MP0002419_abnormal_innate_immunity | 3.07579955 |
| 9 | MP0005387_immune_system_phenotype | 2.90831331 |
| 10 | MP0001790_abnormal_immune_system | 2.90831331 |
| 11 | MP0005025_abnormal_response_to | 2.88935108 |
| 12 | MP0002452_abnormal_antigen_presenting | 2.73604301 |
| 13 | MP0000685_abnormal_immune_system | 2.65061159 |
| 14 | MP0003724_increased_susceptibility_to | 2.64673860 |
| 15 | MP0001800_abnormal_humoral_immune | 2.62186715 |
| 16 | MP0006082_CNS_inflammation | 2.56106574 |
| 17 | MP0002723_abnormal_immune_serum | 2.53188609 |
| 18 | MP0003705_abnormal_hypodermis_morpholog | 2.49977986 |
| 19 | MP0001819_abnormal_immune_cell | 2.49074280 |
| 20 | MP0002420_abnormal_adaptive_immunity | 2.46385298 |
| 21 | MP0002006_tumorigenesis | 2.18765330 |
| 22 | MP0003303_peritoneal_inflammation | 2.17973470 |
| 23 | MP0008260_abnormal_autophagy | 2.15935464 |
| 24 | MP0005451_abnormal_body_composition | 2.07067949 |
| 25 | MP0005464_abnormal_platelet_physiology | 1.97605527 |
| 26 | MP0002405_respiratory_system_inflammati | 1.96063450 |
| 27 | MP0004782_abnormal_surfactant_physiolog | 1.93156667 |
| 28 | MP0002166_altered_tumor_susceptibility | 1.89393755 |
| 29 | MP0002398_abnormal_bone_marrow | 1.89251011 |
| 30 | MP0000716_abnormal_immune_system | 1.81928584 |
| 31 | MP0008438_abnormal_cutaneous_collagen | 1.80469570 |
| 32 | MP0001845_abnormal_inflammatory_respons | 1.78702380 |
| 33 | MP0003448_altered_tumor_morphology | 1.78475550 |
| 34 | MP0005310_abnormal_salivary_gland | 1.76263362 |
| 35 | MP0004510_myositis | 1.74815794 |
| 36 | MP0000858_altered_metastatic_potential | 1.72128101 |
| 37 | MP0001533_abnormal_skeleton_physiology | 1.71356041 |
| 38 | MP0010234_abnormal_vibrissa_follicle | 1.70313045 |
| 39 | MP0009333_abnormal_splenocyte_physiolog | 1.65515018 |
| 40 | MP0001853_heart_inflammation | 1.62390990 |
| 41 | MP0009764_decreased_sensitivity_to | 1.62361276 |
| 42 | MP0010155_abnormal_intestine_physiology | 1.61436092 |
| 43 | MP0003763_abnormal_thymus_physiology | 1.59988269 |
| 44 | MP0000343_altered_response_to | 1.47801987 |
| 45 | MP0000569_abnormal_digit_pigmentation | 1.44447975 |
| 46 | MP0002429_abnormal_blood_cell | 1.44374800 |
| 47 | MP0000689_abnormal_spleen_morphology | 1.43911547 |
| 48 | MP0001545_abnormal_hematopoietic_system | 1.41933946 |
| 49 | MP0005397_hematopoietic_system_phenotyp | 1.41933946 |
| 50 | MP0010307_abnormal_tumor_latency | 1.40072778 |
| 51 | MP0000015_abnormal_ear_pigmentation | 1.37665639 |
| 52 | MP0001958_emphysema | 1.37533189 |
| 53 | MP0005409_darkened_coat_color | 1.35435216 |
| 54 | MP0002722_abnormal_immune_system | 1.33659533 |
| 55 | MP0008469_abnormal_protein_level | 1.31182613 |
| 56 | MP0001851_eye_inflammation | 1.29701777 |
| 57 | MP0002396_abnormal_hematopoietic_system | 1.29449643 |
| 58 | MP0004947_skin_inflammation | 1.27072342 |
| 59 | MP0003075_altered_response_to | 1.26084511 |
| 60 | MP0003172_abnormal_lysosome_physiology | 1.26043281 |
| 61 | MP0005058_abnormal_lysosome_morphology | 1.25683922 |
| 62 | MP0006054_spinal_hemorrhage | 1.24375252 |
| 63 | MP0002277_abnormal_respiratory_mucosa | 1.23480159 |
| 64 | MP0002876_abnormal_thyroid_physiology | 1.19792091 |
| 65 | MP0002998_abnormal_bone_remodeling | 1.19201141 |
| 66 | MP0003221_abnormal_cardiomyocyte_apopto | 1.15434783 |
| 67 | MP0002877_abnormal_melanocyte_morpholog | 1.14800909 |
| 68 | MP0003186_abnormal_redox_activity | 1.13316947 |
| 69 | MP0003453_abnormal_keratinocyte_physiol | 1.11400649 |
| 70 | MP0009278_abnormal_bone_marrow | 1.10541234 |
| 71 | MP0004808_abnormal_hematopoietic_stem | 1.08859424 |
| 72 | MP0003656_abnormal_erythrocyte_physiolo | 1.07629178 |
| 73 | MP0005621_abnormal_cell_physiology | 1.07601192 |
| 74 | MP0005166_decreased_susceptibility_to | 1.04668099 |
| 75 | MP0004264_abnormal_extraembryonic_tissu | 1.02423937 |
| 76 | MP0003279_aneurysm | 1.02414161 |
| 77 | MP0008057_abnormal_DNA_replication | 0.97471018 |
| 78 | MP0002009_preneoplasia | 0.96789746 |
| 79 | MP0005174_abnormal_tail_pigmentation | 0.95232568 |
| 80 | MP0005023_abnormal_wound_healing | 0.95056005 |
| 81 | MP0003183_abnormal_peptide_metabolism | 0.93933268 |
| 82 | MP0000604_amyloidosis | 0.93400837 |
| 83 | MP0001986_abnormal_taste_sensitivity | 0.92873529 |
| 84 | MP0001849_ear_inflammation | 0.92624412 |
| 85 | MP0004185_abnormal_adipocyte_glucose | 0.90660818 |
| 86 | MP0003191_abnormal_cellular_cholesterol | 0.89597123 |
| 87 | MP0002163_abnormal_gland_morphology | 0.89486188 |
| 88 | MP0001348_abnormal_lacrimal_gland | 0.88781391 |
| 89 | MP0008007_abnormal_cellular_replicative | 0.87527301 |
| 90 | MP0003690_abnormal_glial_cell | 0.86987407 |
| 91 | MP0000703_abnormal_thymus_morphology | 0.85017394 |
| 92 | MP0005167_abnormal_blood-brain_barrier | 0.84741881 |
| 93 | MP0000767_abnormal_smooth_muscle | 0.84242154 |
| 94 | MP0002060_abnormal_skin_morphology | 0.83263253 |
| 95 | MP0005076_abnormal_cell_differentiation | 0.82343360 |
| 96 | MP0000490_abnormal_crypts_of | 0.82179636 |
| 97 | MP0008004_abnormal_stomach_pH | 0.79276654 |
| 98 | MP0005164_abnormal_response_to | 0.79029588 |
| 99 | MP0001873_stomach_inflammation | 0.78511373 |
| 100 | MP0002735_abnormal_chemical_nociception | 0.77261622 |
| 101 | MP0005390_skeleton_phenotype | 0.76171699 |
| 102 | MP0003795_abnormal_bone_structure | 0.73727111 |
| 103 | MP0002132_abnormal_respiratory_system | 0.73632151 |
| 104 | MP0003866_abnormal_defecation | 0.73052032 |
| 105 | MP0005384_cellular_phenotype | 0.72593854 |
| 106 | MP0002133_abnormal_respiratory_system | 0.71952892 |
| 107 | MP0005388_respiratory_system_phenotype | 0.71952892 |
| 108 | MP0004381_abnormal_hair_follicle | 0.71328883 |
| 109 | MP0004883_abnormal_blood_vessel | 0.69990955 |
| 110 | MP0009763_increased_sensitivity_to | 0.69324884 |
| 111 | MP0001542_abnormal_bone_strength | 0.69136135 |
| 112 | MP0000465_gastrointestinal_hemorrhage | 0.68232037 |
| 113 | MP0000371_diluted_coat_color | 0.67310786 |
| 114 | MP0003566_abnormal_cell_adhesion | 0.67044848 |
| 115 | MP0002019_abnormal_tumor_incidence | 0.66497142 |
| 116 | MP0001915_intracranial_hemorrhage | 0.65256750 |
| 117 | MP0000249_abnormal_blood_vessel | 0.64702716 |
| 118 | MP0010386_abnormal_urinary_bladder | 0.63788817 |
| 119 | MP0003787_abnormal_imprinting | 0.63147882 |
| 120 | MP0003828_pulmonary_edema | 0.60633875 |
| 121 | MP0005171_absent_coat_pigmentation | 0.60547774 |
| 122 | MP0003091_abnormal_cell_migration | 0.60546868 |
| 123 | MP0003943_abnormal_hepatobiliary_system | 0.59627345 |
| 124 | MP0009697_abnormal_copulation | 0.58521156 |
| 125 | MP0002138_abnormal_hepatobiliary_system | 0.57987939 |
| 126 | MP0002095_abnormal_skin_pigmentation | 0.56953620 |
| 127 | MP0001881_abnormal_mammary_gland | 0.56503037 |
| 128 | MP0010352_gastrointestinal_tract_polyps | 0.55397772 |
| 129 | MP0005084_abnormal_gallbladder_morpholo | 0.53711965 |
| 130 | MP0003693_abnormal_embryo_hatching | 0.53612685 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 6.71982737 |
| 2 | Eczematoid dermatitis (HP:0000976) | 6.19885013 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 6.06030810 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.82026846 |
| 5 | Myositis (HP:0100614) | 4.61706501 |
| 6 | Mediastinal lymphadenopathy (HP:0100721) | 4.58726680 |
| 7 | Autoimmune thrombocytopenia (HP:0001973) | 4.53940783 |
| 8 | Retrobulbar optic neuritis (HP:0100654) | 4.46296184 |
| 9 | Optic neuritis (HP:0100653) | 4.46296184 |
| 10 | Orchitis (HP:0100796) | 4.16081990 |
| 11 | Chronic obstructive pulmonary disease (HP:0006510) | 4.11298853 |
| 12 | Obstructive lung disease (HP:0006536) | 4.11298853 |
| 13 | Increased IgM level (HP:0003496) | 3.96249776 |
| 14 | Abnormality of macrophages (HP:0004311) | 3.92955071 |
| 15 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.83770240 |
| 16 | Recurrent fungal infections (HP:0002841) | 3.54364251 |
| 17 | Vasculitis (HP:0002633) | 3.47719073 |
| 18 | Keratoconjunctivitis sicca (HP:0001097) | 3.46655144 |
| 19 | Recurrent skin infections (HP:0001581) | 3.45295507 |
| 20 | Gingivitis (HP:0000230) | 3.37980929 |
| 21 | Recurrent viral infections (HP:0004429) | 3.28391119 |
| 22 | Systemic lupus erythematosus (HP:0002725) | 3.25298598 |
| 23 | Keratoconjunctivitis (HP:0001096) | 3.21884759 |
| 24 | Meningitis (HP:0001287) | 3.19270294 |
| 25 | Spinal cord lesions (HP:0100561) | 3.10566300 |
| 26 | Syringomyelia (HP:0003396) | 3.10566300 |
| 27 | Periodontitis (HP:0000704) | 3.02661337 |
| 28 | Stomatitis (HP:0010280) | 3.00702905 |
| 29 | Basal ganglia calcification (HP:0002135) | 2.99078012 |
| 30 | Recurrent pneumonia (HP:0006532) | 2.98531902 |
| 31 | Pulmonary infiltrates (HP:0002113) | 2.95186969 |
| 32 | Cellulitis (HP:0100658) | 2.88628725 |
| 33 | Agnosia (HP:0010524) | 2.85917733 |
| 34 | Abnormality of T cell number (HP:0011839) | 2.85911787 |
| 35 | Arterial thrombosis (HP:0004420) | 2.83125660 |
| 36 | Prostate neoplasm (HP:0100787) | 2.81508550 |
| 37 | Hypergammaglobulinemia (HP:0010702) | 2.73653700 |
| 38 | Peritonitis (HP:0002586) | 2.71861338 |
| 39 | Vacuolated lymphocytes (HP:0001922) | 2.70950515 |
| 40 | Abnormality of the prostate (HP:0008775) | 2.60038657 |
| 41 | Osteomyelitis (HP:0002754) | 2.59893533 |
| 42 | Leukocytosis (HP:0001974) | 2.58533755 |
| 43 | Arterial tortuosity (HP:0005116) | 2.56346278 |
| 44 | Recurrent cutaneous fungal infections (HP:0011370) | 2.52532702 |
| 45 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.52532702 |
| 46 | Thyroiditis (HP:0100646) | 2.52312444 |
| 47 | Eosinophilia (HP:0001880) | 2.50755391 |
| 48 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.48582780 |
| 49 | Recurrent lower respiratory tract infections (HP:0002783) | 2.44681685 |
| 50 | T lymphocytopenia (HP:0005403) | 2.43050172 |
| 51 | Thrombocytosis (HP:0001894) | 2.42226535 |
| 52 | Encephalitis (HP:0002383) | 2.40650829 |
| 53 | Gingival bleeding (HP:0000225) | 2.40487076 |
| 54 | Vascular tortuosity (HP:0004948) | 2.39381129 |
| 55 | Pustule (HP:0200039) | 2.38939570 |
| 56 | Gastrointestinal infarctions (HP:0005244) | 2.38806532 |
| 57 | Hemoptysis (HP:0002105) | 2.38701257 |
| 58 | Premature rupture of membranes (HP:0001788) | 2.37457263 |
| 59 | Osteolytic defects of the hand bones (HP:0009699) | 2.35606958 |
| 60 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.35606958 |
| 61 | Dilatation of the ascending aorta (HP:0005111) | 2.35256980 |
| 62 | Subacute progressive viral hepatitis (HP:0006572) | 2.33922576 |
| 63 | Cutaneous melanoma (HP:0012056) | 2.33305743 |
| 64 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.32671841 |
| 65 | Petechiae (HP:0000967) | 2.32330748 |
| 66 | Abnormal platelet volume (HP:0011876) | 2.32280661 |
| 67 | Absent frontal sinuses (HP:0002688) | 2.32240531 |
| 68 | Abnormal hair whorl (HP:0010721) | 2.31259526 |
| 69 | Abnormality of T cells (HP:0002843) | 2.30301930 |
| 70 | Autoimmune hemolytic anemia (HP:0001890) | 2.29417727 |
| 71 | Increased cerebral lipofuscin (HP:0011813) | 2.26647214 |
| 72 | Viral hepatitis (HP:0006562) | 2.26414028 |
| 73 | Spondylolisthesis (HP:0003302) | 2.26015230 |
| 74 | Thick nail (HP:0001805) | 2.25188762 |
| 75 | Abnormality of the peritoneum (HP:0002585) | 2.25006335 |
| 76 | Interstitial pulmonary disease (HP:0006530) | 2.23557432 |
| 77 | Chromsome breakage (HP:0040012) | 2.23418595 |
| 78 | Protrusio acetabuli (HP:0003179) | 2.23305925 |
| 79 | IgG deficiency (HP:0004315) | 2.23183031 |
| 80 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.22262165 |
| 81 | Glomerulopathy (HP:0100820) | 2.22107540 |
| 82 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.20016788 |
| 83 | Sepsis (HP:0100806) | 2.19231035 |
| 84 | Abnormality of glycolipid metabolism (HP:0010969) | 2.18903640 |
| 85 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.18903640 |
| 86 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.18903640 |
| 87 | Poor head control (HP:0002421) | 2.17962882 |
| 88 | Granulocytopenia (HP:0001913) | 2.14779754 |
| 89 | Abnormality of eosinophils (HP:0001879) | 2.14706266 |
| 90 | Epistaxis (HP:0000421) | 2.14694359 |
| 91 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.13753762 |
| 92 | Chronic otitis media (HP:0000389) | 2.13279936 |
| 93 | Chest pain (HP:0100749) | 2.12924699 |
| 94 | Ankyloglossia (HP:0010296) | 2.11395876 |
| 95 | Abnormality of the pleura (HP:0002103) | 2.11352704 |
| 96 | IgA deficiency (HP:0002720) | 2.11171443 |
| 97 | Gangrene (HP:0100758) | 2.11089141 |
| 98 | Cerebral aneurysm (HP:0004944) | 2.10649358 |
| 99 | Abnormality of T cell physiology (HP:0011840) | 2.10522072 |
| 100 | Disinhibition (HP:0000734) | 2.09249130 |
| 101 | Agammaglobulinemia (HP:0004432) | 2.09123563 |
| 102 | Fatigue (HP:0012378) | 2.08916028 |
| 103 | Glomerulonephritis (HP:0000099) | 2.08360817 |
| 104 | Prolonged bleeding time (HP:0003010) | 2.06089808 |
| 105 | Alveolar cell carcinoma (HP:0006519) | 2.05737997 |
| 106 | Myocardial infarction (HP:0001658) | 2.05281630 |
| 107 | Urticaria (HP:0001025) | 2.04068370 |
| 108 | Increased mean platelet volume (HP:0011877) | 2.03707321 |
| 109 | Vertebral compression fractures (HP:0002953) | 2.02893484 |
| 110 | Heterochromia iridis (HP:0001100) | 2.02525990 |
| 111 | Abnormality of oral frenula (HP:0000190) | 2.01556025 |
| 112 | Aortic dissection (HP:0002647) | 2.01072728 |
| 113 | Slow saccadic eye movements (HP:0000514) | 2.00390219 |
| 114 | Amyloidosis (HP:0011034) | 1.99612497 |
| 115 | Anorexia (HP:0002039) | 1.96737121 |
| 116 | Abnormality of the anterior horn cell (HP:0006802) | 1.96566087 |
| 117 | Degeneration of anterior horn cells (HP:0002398) | 1.96566087 |
| 118 | Keratitis (HP:0000491) | 1.95705188 |
| 119 | Severe combined immunodeficiency (HP:0004430) | 1.94927621 |
| 120 | Spontaneous hematomas (HP:0007420) | 1.93058569 |
| 121 | IgM deficiency (HP:0002850) | 1.93006964 |
| 122 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.91758010 |
| 123 | Increased IgE level (HP:0003212) | 1.91752940 |
| 124 | Gastrointestinal inflammation (HP:0004386) | 1.91691266 |
| 125 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.91567993 |
| 126 | Tetraparesis (HP:0002273) | 1.89709886 |
| 127 | Asymmetry of the thorax (HP:0001555) | 1.89589803 |
| 128 | Recurrent bronchitis (HP:0002837) | 1.89185667 |
| 129 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.89081254 |
| 130 | Inflammation of the large intestine (HP:0002037) | 1.87216130 |
| 131 | Skin ulcer (HP:0200042) | 1.87035895 |
| 132 | Aortic aneurysm (HP:0004942) | 1.83710347 |
| 133 | Insidious onset (HP:0003587) | 1.81154920 |
| 134 | Termporal pattern (HP:0011008) | 1.81154920 |
| 135 | Polycythemia (HP:0001901) | 1.79303118 |
| 136 | Loss of speech (HP:0002371) | 1.78444333 |
| 137 | Flat acetabular roof (HP:0003180) | 1.77719085 |
| 138 | Orthostatic hypotension (HP:0001278) | 1.77144322 |
| 139 | Amaurosis fugax (HP:0100576) | 1.75567810 |
| 140 | Mitral valve prolapse (HP:0001634) | 1.70920555 |
| 141 | Colitis (HP:0002583) | 1.70779753 |
| 142 | Dysostosis multiplex (HP:0000943) | 1.67517063 |
| 143 | Gastrointestinal stroma tumor (HP:0100723) | 1.63583791 |
| 144 | Papillary thyroid carcinoma (HP:0002895) | 1.63052985 |
| 145 | Abnormality of the common coagulation pathway (HP:0010990) | 1.62865295 |
| 146 | Aneurysm (HP:0002617) | 1.62109906 |
| 147 | Papilloma (HP:0012740) | 1.59206769 |
| 148 | Verrucae (HP:0200043) | 1.59206769 |
| 149 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.58579210 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 3.72088079 |
| 2 | IRAK4 | 3.32082040 |
| 3 | TXK | 3.19977719 |
| 4 | BMPR2 | 3.05831744 |
| 5 | SIK3 | 2.99130130 |
| 6 | * MAP3K14 | 2.85179949 |
| 7 | BLK | 2.82440232 |
| 8 | ERBB3 | 2.77112092 |
| 9 | MAP3K12 | 2.44567823 |
| 10 | JAK3 | 2.43158460 |
| 11 | CDK12 | 2.34667347 |
| 12 | IRAK3 | 2.31049909 |
| 13 | NEK9 | 2.23684471 |
| 14 | TBK1 | 2.15761761 |
| 15 | IKBKE | 2.14500986 |
| 16 | MST4 | 2.12503995 |
| 17 | ERN1 | 2.07566875 |
| 18 | MAP4K1 | 2.02342299 |
| 19 | TRIB3 | 2.02153001 |
| 20 | IKBKB | 2.00683507 |
| 21 | TYK2 | 1.98823022 |
| 22 | MAP2K3 | 1.93562739 |
| 23 | PBK | 1.85731184 |
| 24 | PIM2 | 1.83912938 |
| 25 | FGFR4 | 1.78955643 |
| 26 | KSR2 | 1.76741274 |
| 27 | PLK2 | 1.70166079 |
| 28 | JAK1 | 1.64346196 |
| 29 | SYK | 1.64227396 |
| 30 | SMG1 | 1.60941577 |
| 31 | PRPF4B | 1.60154410 |
| 32 | CLK1 | 1.56257131 |
| 33 | CHUK | 1.50015014 |
| 34 | MAP3K10 | 1.48090699 |
| 35 | TRPM7 | 1.44968842 |
| 36 | TEC | 1.43142755 |
| 37 | EPHB1 | 1.42468761 |
| 38 | FGR | 1.41786594 |
| 39 | KIT | 1.38862666 |
| 40 | CASK | 1.38088479 |
| 41 | PIM1 | 1.36650985 |
| 42 | PDGFRA | 1.36394489 |
| 43 | ZAP70 | 1.31748538 |
| 44 | MAP3K13 | 1.24867828 |
| 45 | BCR | 1.23331341 |
| 46 | SGK2 | 1.21219925 |
| 47 | KSR1 | 1.19070793 |
| 48 | TGFBR2 | 1.18975414 |
| 49 | ARAF | 1.18952523 |
| 50 | EIF2AK2 | 1.18265380 |
| 51 | YES1 | 1.17737285 |
| 52 | AKT3 | 1.13283028 |
| 53 | BTK | 1.12344247 |
| 54 | FGFR3 | 1.12096827 |
| 55 | MAP3K1 | 1.11216918 |
| 56 | EIF2AK1 | 1.09734481 |
| 57 | ZAK | 1.07866103 |
| 58 | MAP3K2 | 1.07341614 |
| 59 | BRD4 | 1.05348763 |
| 60 | LYN | 1.05076877 |
| 61 | RIPK1 | 1.03203399 |
| 62 | CSK | 1.00500664 |
| 63 | MAP3K3 | 1.00500330 |
| 64 | HCK | 1.00077249 |
| 65 | STK24 | 0.99766166 |
| 66 | MOS | 0.99686732 |
| 67 | LATS2 | 0.97497015 |
| 68 | TTN | 0.95521388 |
| 69 | PAK4 | 0.95394773 |
| 70 | MARK3 | 0.93972382 |
| 71 | MAP3K6 | 0.90757201 |
| 72 | LCK | 0.90494437 |
| 73 | ICK | 0.88633484 |
| 74 | STK4 | 0.88576328 |
| 75 | LRRK2 | 0.88506044 |
| 76 | SGK3 | 0.87144296 |
| 77 | TESK1 | 0.86036482 |
| 78 | MAP3K9 | 0.85562575 |
| 79 | PKN2 | 0.84221432 |
| 80 | FRK | 0.81768917 |
| 81 | PIK3CG | 0.79554957 |
| 82 | PTK6 | 0.79554250 |
| 83 | ALK | 0.78105211 |
| 84 | CDK4 | 0.76726130 |
| 85 | EEF2K | 0.76543766 |
| 86 | PRKCD | 0.76420482 |
| 87 | NEK6 | 0.76399170 |
| 88 | PLK3 | 0.74955607 |
| 89 | RET | 0.74192805 |
| 90 | ABL2 | 0.73956874 |
| 91 | CSF1R | 0.73404510 |
| 92 | MAP3K8 | 0.73290422 |
| 93 | PDPK1 | 0.73005671 |
| 94 | ADRBK2 | 0.71828957 |
| 95 | PDK1 | 0.71804335 |
| 96 | MATK | 0.71634371 |
| 97 | DAPK1 | 0.71259010 |
| 98 | PDGFRB | 0.70347747 |
| 99 | BRSK2 | 0.70268289 |
| 100 | NUAK1 | 0.69387454 |
| 101 | WNK1 | 0.69351810 |
| 102 | EIF2AK3 | 0.68122962 |
| 103 | TAOK2 | 0.67713953 |
| 104 | IRAK2 | 0.66902886 |
| 105 | RPS6KA6 | 0.66154139 |
| 106 | ITK | 0.64034873 |
| 107 | CDC42BPA | 0.63219249 |
| 108 | JAK2 | 0.62708895 |
| 109 | PRKCQ | 0.62359270 |
| 110 | FES | 0.61002974 |
| 111 | RPS6KL1 | 0.59292147 |
| 112 | RPS6KC1 | 0.59292147 |
| 113 | TSSK6 | 0.58784941 |
| 114 | MKNK1 | 0.52779062 |
| 115 | STK10 | 0.52231196 |
| 116 | BMPR1B | 0.51707056 |
| 117 | PLK4 | 0.50643126 |
| 118 | RPS6KB1 | 0.49789379 |
| 119 | IRAK1 | 0.49632813 |
| 120 | MAPKAPK2 | 0.49546814 |
| 121 | GRK7 | 0.47894845 |
| 122 | FYN | 0.47505645 |
| 123 | SCYL2 | 0.46831386 |
| 124 | MAP2K7 | 0.43534006 |
| 125 | SIK1 | 0.42751017 |
| 126 | MINK1 | 0.42431453 |
| 127 | GRK6 | 0.42186634 |
| 128 | MAP3K5 | 0.41351854 |
| 129 | NTRK1 | 0.41206556 |
| 130 | MELK | 0.40886989 |
| 131 | MAPK7 | 0.40277470 |
| 132 | ABL1 | 0.39664105 |
| 133 | RPS6KA2 | 0.37384181 |
| 134 | PAK2 | 0.36965650 |
| 135 | MAPK11 | 0.36716313 |
| 136 | ROCK2 | 0.36681831 |
| 137 | BRAF | 0.36144989 |
| 138 | RPS6KB2 | 0.36096987 |
| 139 | CDK9 | 0.35888734 |
| 140 | LATS1 | 0.35680276 |
| 141 | CAMKK2 | 0.35552168 |
| 142 | CDK6 | 0.34983015 |
| 143 | CAMKK1 | 0.34485410 |
| 144 | TAOK3 | 0.33596112 |
| 145 | MKNK2 | 0.33141506 |
| 146 | BMX | 0.32193171 |
| 147 | NME2 | 0.31181436 |
| 148 | RPS6KA4 | 0.31140605 |
| 149 | SGK223 | 0.30031475 |
| 150 | SGK494 | 0.30031475 |
| 151 | CCNB1 | 0.28647999 |
| 152 | EGFR | 0.26965245 |
| 153 | SRPK1 | 0.26519175 |
| 154 | RAF1 | 0.25639628 |
| 155 | SGK1 | 0.24044988 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.48122334 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 3.26936847 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.85512159 |
| 4 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.45858094 |
| 5 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.38107999 |
| 6 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.36043118 |
| 7 | Legionellosis_Homo sapiens_hsa05134 | 2.28507912 |
| 8 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.23708648 |
| 9 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.12294884 |
| 10 | Measles_Homo sapiens_hsa05162 | 2.09169100 |
| 11 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.08194146 |
| 12 | Pertussis_Homo sapiens_hsa05133 | 1.98654830 |
| 13 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.98591527 |
| 14 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.96886105 |
| 15 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.96541981 |
| 16 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.95602047 |
| 17 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.91221181 |
| 18 | Tuberculosis_Homo sapiens_hsa05152 | 1.89058643 |
| 19 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.87891553 |
| 20 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.80533917 |
| 21 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.79516337 |
| 22 | Asthma_Homo sapiens_hsa05310 | 1.77091774 |
| 23 | Phagosome_Homo sapiens_hsa04145 | 1.76657620 |
| 24 | Influenza A_Homo sapiens_hsa05164 | 1.76545817 |
| 25 | Salmonella infection_Homo sapiens_hsa05132 | 1.75034071 |
| 26 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.61000255 |
| 27 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.60050402 |
| 28 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.54156172 |
| 29 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.46071717 |
| 30 | Shigellosis_Homo sapiens_hsa05131 | 1.43938218 |
| 31 | Malaria_Homo sapiens_hsa05144 | 1.42754429 |
| 32 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.42325366 |
| 33 | Viral myocarditis_Homo sapiens_hsa05416 | 1.41510718 |
| 34 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.39126734 |
| 35 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.36148344 |
| 36 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.36130287 |
| 37 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.33921324 |
| 38 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.32107460 |
| 39 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.29665661 |
| 40 | Proteasome_Homo sapiens_hsa03050 | 1.24433132 |
| 41 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.24370991 |
| 42 | Apoptosis_Homo sapiens_hsa04210 | 1.23289193 |
| 43 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.21236816 |
| 44 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.15648787 |
| 45 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.15542268 |
| 46 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.15148553 |
| 47 | Lysosome_Homo sapiens_hsa04142 | 1.09533804 |
| 48 | Hepatitis B_Homo sapiens_hsa05161 | 1.07530893 |
| 49 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.06701221 |
| 50 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.05344181 |
| 51 | Colorectal cancer_Homo sapiens_hsa05210 | 0.99453723 |
| 52 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.98991260 |
| 53 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.97295554 |
| 54 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.96149073 |
| 55 | Focal adhesion_Homo sapiens_hsa04510 | 0.94252784 |
| 56 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.94067645 |
| 57 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.93290768 |
| 58 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.92041374 |
| 59 | Bladder cancer_Homo sapiens_hsa05219 | 0.91385622 |
| 60 | Prostate cancer_Homo sapiens_hsa05215 | 0.90986985 |
| 61 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.90551394 |
| 62 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.87335792 |
| 63 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.83089424 |
| 64 | Adherens junction_Homo sapiens_hsa04520 | 0.83070872 |
| 65 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.81634362 |
| 66 | Hepatitis C_Homo sapiens_hsa05160 | 0.81096293 |
| 67 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.80363233 |
| 68 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.78125487 |
| 69 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.77805706 |
| 70 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.77533767 |
| 71 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.75989618 |
| 72 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.75280829 |
| 73 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.73472815 |
| 74 | Other glycan degradation_Homo sapiens_hsa00511 | 0.73246907 |
| 75 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.72975814 |
| 76 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.72928983 |
| 77 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.72838583 |
| 78 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.72259598 |
| 79 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.70591272 |
| 80 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.70539953 |
| 81 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.70354516 |
| 82 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.66467977 |
| 83 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.65254146 |
| 84 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.63735815 |
| 85 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.63256668 |
| 86 | Platelet activation_Homo sapiens_hsa04611 | 0.59778607 |
| 87 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.58835740 |
| 88 | DNA replication_Homo sapiens_hsa03030 | 0.58109336 |
| 89 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.55045501 |
| 90 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.53024227 |
| 91 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.52332143 |
| 92 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.52266963 |
| 93 | Base excision repair_Homo sapiens_hsa03410 | 0.51052932 |
| 94 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.49805478 |
| 95 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.49403776 |
| 96 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.48519942 |
| 97 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.44019404 |
| 98 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.43002145 |
| 99 | Amoebiasis_Homo sapiens_hsa05146 | 0.40392788 |
| 100 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.38329265 |
| 101 | Prion diseases_Homo sapiens_hsa05020 | 0.37344135 |
| 102 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.37307657 |
| 103 | HTLV-I infection_Homo sapiens_hsa05166 | 0.35517796 |
| 104 | Thyroid cancer_Homo sapiens_hsa05216 | 0.34660395 |
| 105 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.33616938 |
| 106 | Homologous recombination_Homo sapiens_hsa03440 | 0.33491747 |
| 107 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.33251648 |
| 108 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.30503046 |
| 109 | Olfactory transduction_Homo sapiens_hsa04740 | 0.29652586 |
| 110 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.28661319 |
| 111 | Mismatch repair_Homo sapiens_hsa03430 | 0.26337185 |
| 112 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.24277860 |
| 113 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.24200933 |
| 114 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.23211211 |
| 115 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.22019903 |
| 116 | Endometrial cancer_Homo sapiens_hsa05213 | 0.21451112 |
| 117 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.21171816 |
| 118 | Long-term potentiation_Homo sapiens_hsa04720 | 0.20323833 |
| 119 | Melanoma_Homo sapiens_hsa05218 | 0.20105993 |
| 120 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.20056543 |
| 121 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.20029034 |
| 122 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.19417386 |
| 123 | Glioma_Homo sapiens_hsa05214 | 0.18727419 |
| 124 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.18295092 |
| 125 | Endocytosis_Homo sapiens_hsa04144 | 0.17622946 |

